Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome

Metabolic syndrome (MS) is becoming the leading risk factor for hepatocellular carcinoma (HCC). HCC development related to MS may occur in advanced or non-advanced liver fibrosis, suggesting specific molecular pathways. Among these pathways, basal inflammatory state and adipokines production are inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Laouirem, Samira, Sannier, Aurélie, Norkowski, Emma, Cauchy, François, Doblas, Sabrina, Rautou, Pierre Emmanuel, Albuquerque, Miguel, Garteiser, Philippe, Sognigbé, Laura, Raffenne, Jerôme, van Beers, Bernard E., Soubrane, Olivier, Bedossa, Pierre, Cros, Jerôme, Paradis, Valérie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484689/
https://www.ncbi.nlm.nih.gov/pubmed/30575815
http://dx.doi.org/10.1038/s41388-018-0597-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484689/
https://www.ncbi.nlm.nih.gov/pubmed/30575815
http://dx.doi.org/10.1038/s41388-018-0597-1

Ejemplares similares